In this study, we analyzed transcriptomes of wild-type and drug-resistant A549 cells by RNA-seq and explored SLC7A2 expression profiles and associated recurrence-free survival (RFS) of NSCLC patients in available databases and patient’s tissues. Here, SLC7A2 is linked to non-small cell lung carcinoma.